BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30106866)

  • 1. Adverse Drug Event-Related Admissions to a Pediatric Emergency Unit.
    Carvalho IV; de Sousa VM; Visacri MB; Quintanilha JCF; de Souza CM; Ambrósio RFL; Reis MCD; de Queiroz RA; Mazzola PG; Galvao TF; Moriel P
    Pediatr Emerg Care; 2021 Apr; 37(4):e152-e158. PubMed ID: 30106866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication-related emergency department visits and hospital admissions in pediatric patients: a qualitative systematic review.
    Zed PJ; Haughn C; Black KJ; Fitzpatrick EA; Ackroyd-Stolarz S; Murphy NG; MacKinnon NJ; Curran JA; Sinclair D
    J Pediatr; 2013 Aug; 163(2):477-83. PubMed ID: 23465404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Drug Events Detected by Clinical Pharmacists in an Emergency Department: A Prospective Monocentric Observational Study.
    Laureau M; Vuillot O; Gourhant V; Perier D; Pinzani V; Lohan L; Faucanie M; Macioce V; Marin G; Giraud I; Jalabert A; Villiet M; Castet-Nicolas A; Sebbane M; Breuker C
    J Patient Saf; 2021 Dec; 17(8):e1040-e1049. PubMed ID: 32175969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital admissions caused by adverse drug events: an Australian prospective study.
    Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
    Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
    Kunac DL; Kennedy J; Austin N; Reith D
    Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric adverse drug events in the outpatient setting: an 11-year national analysis.
    Bourgeois FT; Mandl KD; Valim C; Shannon MW
    Pediatrics; 2009 Oct; 124(4):e744-50. PubMed ID: 19786435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug events in emergency department population: a prospective Italian study.
    Trifirò G; Calogero G; Ippolito FM; Cosentino M; Giuliani R; Conforti A; Venegoni M; Mazzaglia G; Caputi AP
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):333-40. PubMed ID: 15682429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication errors and adverse drug events in pediatric inpatients.
    Kaushal R; Bates DW; Landrigan C; McKenna KJ; Clapp MD; Federico F; Goldmann DA
    JAMA; 2001 Apr; 285(16):2114-20. PubMed ID: 11311101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of emergency department pharmacists on drug overuse and drug underuse in patients with an ADE-related hospitalisation: a controlled intervention study.
    Rahman RN; Nikolik B; de Ridder MAJ; Hoek AE; Janssen MJA; Schuit SCE; Karapinar-Çarkit F; van den Bemt PMLA
    BMC Health Serv Res; 2022 Nov; 22(1):1363. PubMed ID: 36397102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected adverse drug events requiring emergency department visits or hospital admissions.
    Raschetti R; Morgutti M; Menniti-Ippolito F; Belisari A; Rossignoli A; Longhini P; La Guidara C
    Eur J Clin Pharmacol; 1999 Feb; 54(12):959-63. PubMed ID: 10192758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.
    Lo Giudice I; Mocciaro E; Giardina C; Barbieri MA; Cicala G; Gioffrè-Florio M; Carpinteri G; Di Grande A; Spina E; Arcoraci V; Cutroneo PM
    BMC Pharmacol Toxicol; 2019 Apr; 20(1):21. PubMed ID: 31029178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.
    Roulet L; Ballereau F; Hardouin JB; Chiffoleau A; Potel G; Asseray N
    J Emerg Med; 2014 Jun; 46(6):857-64. PubMed ID: 24565882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Professional, structural and organisational interventions in primary care for reducing medication errors.
    Khalil H; Bell B; Chambers H; Sheikh A; Avery AJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003942. PubMed ID: 28977687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency hospitalizations for adverse drug events in China: Clinical pharmacists' approach to assessment and categorization.
    Zhang Y; Jin L; Zhang X; Bai R; Chen D; Ma Y; Zhai X
    Pharmacoepidemiol Drug Saf; 2021 May; 30(5):636-643. PubMed ID: 33630347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cough and cold medication adverse events after market withdrawal and labeling revision.
    Hampton LM; Nguyen DB; Edwards JR; Budnitz DS
    Pediatrics; 2013 Dec; 132(6):1047-54. PubMed ID: 24218462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional surveillance of emergency-department visits for outpatient adverse drug events.
    Capuano A; Irpino A; Gallo M; Ferrante L; Illiano ML; Rinaldi B; Filippelli A; Rossi F
    Eur J Clin Pharmacol; 2009 Jul; 65(7):721-8. PubMed ID: 19294371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency department visits caused by adverse drug events: results of a French survey.
    Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X; Lapostolle F; Borron SW; Adnet F;
    Drug Saf; 2007; 30(1):81-8. PubMed ID: 17194173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing a clinical pharmacy survey of adverse drug events in a French emergency department.
    Roulet L; Asseray N; Dary M; Chiffoleau A; Potel G; Ballereau F
    Int J Clin Pharm; 2012 Dec; 34(6):902-10. PubMed ID: 22923368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.